Results

Total Results: 2,214 records

Showing results for "tissue".

  1. www.uspreventiveservicestaskforce.org/uspstf/document/c-reactive-protein-as-a-risk-factor-for-coronary-heart-disease-a-systematic-review-and-meta-analyses-for-the-us-preventive-services-task-force/coronary-heart-disease-screening-using-non-traditional-risk-factors-2009
    July 15, 2008 - Tissue-type plasminogen activator and C-reactive protein in acute coronary heart disease.
  2. www.uspreventiveservicestaskforce.org/home/getfilebytoken/zVVRY6wa4Sgj-EJb3BRcVy
    November 01, 2013 - or other nonma- lignant high-risk breast lesions, previous breast biopsy, and extremely dense breast tissue
  3. hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2005.jsp
    January 01, 2005 - Complications of pregnancy, childbirth, and the puerperium, (12) Diseases of the skin and subcutaneous tissue
  4. meps.ahrq.gov/data_files/publications/mr36/mr36dr.shtml
    February 24, 2023 - Lymphoma (non-Hodgkin's) CAMELANO - Skin melanoma CAMUSCLE - Soft tissue
  5. www.ahrq.gov/sites/default/files/2024-11/gershon-report.pdf
    January 01, 2024 - system disease diagnoses (27.6%), followed by diseases of the musculoskeletal system and connective tissue
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/tonsillectomy-disposition-170415.pdf
    January 17, 2017 - mask would not reach the upper airway due to the obstruction caused by the enlarged lymphadenoid tissues
  7. digital.ahrq.gov/sites/default/files/docs/publication/r18hs017270-fricton-final-report-2011.pdf
    January 01, 2011 - gland disease or medication that a patient is taking.35 The patient also may experience burning of the tissues
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/tinnitus_research-protocol.pdf
    February 22, 2012 - chamber containing an atmosphere of 100 percent oxygen, which increases the oxygen supply to body tissues
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-pancreas_research-protocol.pdf
    August 09, 2013 - electromagnetic fields and radiofrequency radiation translate hydrogen nuclei distribution in body tissues
  10. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-194-fullreport.pdf
    April 01, 2019 - Children have developing cellular structures and tissues that are significantly more radio-sensitive
  11. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0198-fullreport.pdf
    November 01, 2019 - radiation dose for pediatric patients is highly problematic because developing cellular structures and tissues
  12. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-192-fullreport.pdf
    November 01, 2019 - radiation dose for pediatric patients is highly problematic because developing cellular structures and tissues
  13. effectivehealthcare.ahrq.gov/health-topics/blood
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/prioritization-selection-of-harms.pdf
    February 01, 2018 - pneumonia; surgical site infection; nerve damage; salivary gland damage; ranulae; scarring; soft tissue
  15. effectivehealthcare.ahrq.gov/sites/default/files/ch_6-user-guide-to-ocer_130129.pdf
    October 30, 2012 - act through binding to estrogen receptors to block the proliferative effect of estrogen on mammary tissue
  16. MAINTAIN AND EXPAND (pdf file)

    hcup-us.ahrq.gov/reports/methods/2011_03.pdf
    January 01, 2011 - involving nervous and musculoskeletal systems 782 Symptoms involving skin and other integumentary tissue
  17. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0197-fullreport.pdf
    November 01, 2019 - radiation dose for pediatric patients is highly problematic because the developing cellular structures and tissues
  18. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-196-fullreport.pdf
    January 01, 2020 - radiation dose for pediatric patients is highly problematic because developing cellular structures and tissues
  19. effectivehealthcare.ahrq.gov/health-topics/peripheral-arterial-disease
  20. effectivehealthcare.ahrq.gov/health-topics/cancer-immunotherapy